In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

In a recent antitrust arbitration ruling, Prime Therapeutics, a pharmacy benefit manager (PBM) owned by 19 Blue Cross and ...

Who else could be on the move between now and the trade deadline? We'll have the latest reports and news from our NBA insiders from around the league. MORE: Trade tracker | Trade grades | Outlook ...